Frank van Leth has an extensive research portfolio in the fields of HIV and tuberculosis. As an epidemiologist, he has an affinity for contextually relevant methodological approaches for capturing public health needs and designing appropriate interventions. His current line of research is in the field of antimicrobial resistance, with particluar attention to surveillance methodology
. Vice-director of the Amsterdam Public Health (APH) research institute
. Member WHO expert group antimicrobial resistance prevalence surveys
. Member adjudication committee MTBVAC randomized controlled trial
. Associate Editor Journal of Epidemiology and Community Health,
Collaborations: Padjadjaran University, Jakarta, Indonesia; Univerisity of Sumatera Utara, Medan, Indonesia; Institute of Tropical Medicine, Antwerp, Belgium; HIV-NAT / Thai Red Cross Hopsital, Bangkok, Thailand; Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand; Universitaetsklinikum Heidelberg, Germany; Schweizerisches Tropen- und Public Health-Institut, Basel, Switzerland; University of Eswatini, Kwaluseni, Eswatini; Georg-August-Universität Göttingen, Germany; Folkhelseinstituttet, Norway; Clinton Health Access Initiative, Mbabane, Eswatini; Swaziland Business Coalition on Health and AIDS; Diabetes Swaziland, Manzini, Eswatini.
Frank van leth served as the chair of TBnet (2016-2020), a European consortium with over 800 members dedicated to collaborative basic, translational, clinical, and applied TB research.
He is a former Associate Editor of the International Journal of Tuberculosis and Lung Diseases (2006 - 2021)
